FindTrial
Sign In

Application of wechat platform in health management of patients with gastroesophageal reflux disease

Application of wechat platform in health management of patients with gastroesophageal reflux disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059254
Enrollment
Unknown
Registered
2022-04-27
Start date
2022-04-20
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease

Interventions

The experimental group:Wechat platform publicity and education

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have typical symptoms of gastroesophageal reflux disease, esophagitis found by endoscopy or effective PPI experimental treatment in our outpatient department; 2. 18-70 years old; 3. The patient or his family will use WeChat; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with serious mental illness, serious acute and chronic diseases; 2. Patients with complications of gastroesophageal reflux disease; 3. Patients with other digestive system diseases; 4. Recently used PPI/H2RA and other drugs.

Design outcomes

Primary

MeasureTime frame
Gastroesophageal reflux disease symptom questionnaire;Gastroesophageal reflux disease questionnaire;—

Countries

China

Contacts

Public ContactYanbo Yu

Qilu Hospital of Shandong University

yuyanbo2000@126.com+86 18560086102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026